(Reuters) - The FDA sent Glaxo a warning letter in July 2001 after its
own monitoring, saying the company's sales representatives had
played down safety concerns and asking the company to send out a
letter to doctors warning them of the risks.
The company sent out the letters on Sept. 6, 2001, according
to an article in the New York Times, which first reported the
story.
Read more at Reuters.com Government Filings News
own monitoring, saying the company's sales representatives had
played down safety concerns and asking the company to send out a
letter to doctors warning them of the risks.
The company sent out the letters on Sept. 6, 2001, according
to an article in the New York Times, which first reported the
story.
Read more at Reuters.com Government Filings News
No comments:
Post a Comment